Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nandrolone (19-nortestosterone) is an anabolic-androgenic steroid (AAS) that promotes muscle growth and increases red blood cell production. It acts as an agonist of the androgen receptor (AR) and the progesterone receptor (PR). Nandrolone is derived from prohormones such as 4-norandrostenedione and 4-norandrostenediol through metabolic conversion in the body.
Nandrolone binds to the androgen receptor (AR) and progesterone receptor (PR), leading to increased protein synthesis and anabolic effects. Its lower androgenicity compared to testosterone in some tissues is due to its conversion to a less potent metabolite by 5α-reductase.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nandrolone (19-Nortestosterone).